Aurelian is a dedicated bridge for innovative therapies, acquiring rights to strong candidates in hematology/oncology and rare diseases that demonstrate significant potential for patient impact. We evaluate clinical data to advance promising assets through development and commercialization, bridging them to US and MENA markets with non-dilutive, milestone-based funding.
Our lean model, minimizes overhead to drive higher returns while prioritizing unmet needs in niche conditions. Focusing on patient-centric solutions, we deliver superior outcomes and value for all stakeholders.

Aurelian Life Sciences

Org chart

Teams

Offices